Global Non-Invasive Prenatal Testing (NIPT) Market By Top Players: Sequenom, Roche (Ariosa Diagnostics); Natera, LabCorp, BGI Genomics; Quest Diagnostics, Illumina, Laboratory Corporation of America Holdings, Yourgene Health, and Berry Genomics.
In April 2017, Illumina, Inc. introduced VeriSeq NIPT solution in Europe (CE marked), which is useful for screening Trisomy (Down’s syndrome, Sex Chromosome Disorders, Microdeletion Syndrome).
In January 2019, Yourgene Health plc (U.K.) launched the Sage 32 plex test which uses Thermo Fisher’s Ion Torrent sequencing technology to detect placental cff-DNA in a maternal blood sample.
Sample Copy of Reports: https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/4519
High risk of chromosomal abnormalities with increasing maternal age
Maternal age plays an important role in the health of the child and delay in the maternal age can lead to various risk such as decreased fertility, high blood pressure, and an increase in the risk of miscarriage, stillbirths, and maternal death. Moreover, advancing maternal age can increase the risk of genetic disorders in babies as a result of the improper chromosomal division. The resulting abnormalities in babies may include microcephaly; short neck; upward slanted eyes; poor muscle tone; and heart, intestine, and breathing problems. In order to detect genetic abnormalities resulting from improper chromosomal division, there is a growing demand for early screening in expecting mothers. Therefore, Non-invasive prenatal testing being the safest one is boosting the market.
Key Market Insights from the report:
The global non-invasive prenatal testing (NIPT) market accounted for US$ 4.3 billion in 2020 and is estimated to be US$ 11.8 billion by 2029 and is anticipated to register a CAGR of 11.9%. The market report has been segmented on the basis of product type, technique, application, end-user and region.
Depending upon product type, consumables segment dominated the overall NIPT market. The growth of this segment is mainly because of the increasing incidences of chromosomal abnormalities, rise in the number of tests and products for NIPT, and improvement of approvals or licenses for assays.
In terms of technique, the cfDNA segment is expected to show the highest CAGR during the forecast period due to technological advancements and increasing company initiatives to develop new products.
By application, trisomy segment dominates the market due to the increasing maternal age and the rising incidence of chromosomal abnormalities.
Based on the end user, diagnostic laboratories are estimated to have the highest revenue share due to the implementation of initiatives by diagnostic laboratories to provide safe and effective prenatal tests and rising incidence of chromosomal abnormalities.
By region, North America accounted for the largest market share, followed by Europe. On the other hand, Asia is expected to grow at the highest CAGR during the forecast period. The reason being the developing healthcare infrastructure, rising awareness programs & conferences, and rising focus of prominent players on expanding their presence in these regions.
Get In-depth @ https://www.prophecymarketinsights.com/market_insight/Global-Non-Invasive-Prenatal-Testing-(NIPT)-Market-4519
Some Important Points Answered in this Market Report Are Given Below:
Explains an overview of the product portfolio, including product development, planning, and positioning
Explains details about key operational strategies with a focus on R&D strategies, corporate structure, localization strategies, production capabilities, and financial performance of various companies.
Detailed analysis of the market revenue over the forecasted period.
Examining various outlooks of the market with the help of Porter’s five forces analysis, PEST & SWOT Analysis.
Study on the segments that are anticipated to dominate the market.
Study on the regional analysis that is expected to register the highest growth over the forecast period
Roche (Ariosa Diagnostics)
Laboratory Corporation of America Holdings
Prophecy Market Insights
Phone: +1 860 531 2701
About Prophecy Market Insights
Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Non-Invasive Prenatal Testing (NIPT) Market By Top Players: Sequenom, Roche (Ariosa Diagnostics); Natera, LabCorp, BGI Genomics; Quest Diagnostics, Illumina, Laboratory Corporation of America Holdings, Yourgene Health, and Berry Genomics. here
News-ID: 2236373 • Views: 809
More Releases from Prophecy Market Insights
Global Robotics Surgical Simulation Systems Market is estimated to be US$ 2178.2 …
The Global Robotics Surgical Simulation Systems Market accounted for US$ 464.8 million in 2020 and is estimated to be US$ 2178.2 million by 2030 and is anticipated to register a CAGR of 16.9%. Robotics surgical simulation systems are the advance technology which holds lots of potentials to transfigure the surgical education practices. The developments in computational technologies amplified by the immeasurable knowledge of the functioning of the human body have
Global Cancer ALK Inhibitor Market || Keyplayers Takeda Pharmaceutical Co. Ltd., …
The Global Cancer ALK Inhibitor Market accounted for US$ 2.96 million in 2020 and is estimated to be US$ 23.1 million by 2030 and is anticipated to register a CAGR of 20%. ALK inhibitors are anti-cancer drugs that acts on tumors with variations of anaplastic lymphoma kinase such as EML4-ALK translocation and falls in the category of tyrosine kinase inhibitors, which work by inhibiting proteins involved in abnormal growth of
Global Cell and Gene Therapy Market worth US$ 1.8 billion 2019 with a CAGR of 35 …
The report "Global Cell and Gene Therapy Market, By Products (Cell Therapy, and Gene Therapy), By Distribution Channel Type (Oncology, Dermatology, Musculoskeletal, and Others), By End-Users (Hospitals, Wound Care Centers, Cancer Care Centers, Ambulatory Surgical Centers, and Others), and Region - Global Forecast to 2030" global cell and gene therapy market is projected to grow from US$ 1.8 billion in 2019. The major factor driving the global cell and gene
Global Food Flavor Market is estimated to be US$ 27.7 Bn by 2030 with a CAGR of …
The significant growth of the food flavor market is increasing due to consumer gaining interest towards purchasing clean label goods, which offers wide scope for sources with natural ingredients. Interest in ethnic or exotic flavors is one of the key drivers of the food flavor market. The report "Global Food Flavor Market, By Form (Liquid, Dry, Gas), By Type (Natural, Synthetic), By Flavor Ingredients (Alcoholic Note Flavor, Cocoa, Berries, coffee, citrus,
More Releases for NIPT
Non-invasive Prenatal Testing (NIPT) Market - Screening Opportunities 2025
Global Non-invasive Prenatal Testing (NIPT) Market: Overview The growing preference for non-invasive techniques over invasive surgeries is one of the key growth drivers for the global non-invasive prenatal testing (NIPT) market. In addition to this number of babies born with Down syndrome, XYY syndrome, Turner, and Klinefelter is increasing, boosting the growth of the market. These chromosomal aneuploidies occur as a result of infertility, reproductive loss, and language development delays
United States Non-Invasive Prenatal Testing (NIPT) Market 2023
United States Non-Invasive Prenatal Testing (NIPT) Industry United States Non-Invasive Prenatal Testing (NIPT) Market is likely to reach nearly USD 1 Billion by the year end of 2023. Latest Report on Non-Invasive Prenatal Testing (NIPT) Market United States Analysis & 2023 Forecast Research Study Market growth can be attributed to factors such as rapid penetration of high and average risk NIPT test, high incidence rate of babies born with down syndrome, no risk
China $1.7 NIPT Test Market Outlook 2017-2024
China Potential Non–Invasive Prenatal Testing (NIPT) market is likely to reach more than US$ 1.7 Billion by 2024. Long–term Growth Projection and Development: • It is predicted that China Actual NIPT test volume will increase to 1.6 Million by 2024 • More than 3,00,000 NIFTY tests done in 2016 • Berry Genomics completes US$ 648 Million reverse merger in Shenzhen • Two–Child policy is likely to boost China NIPT market Growth in China NIPT market can
Non-invasive Prenatal Testing (NIPT) Market | Forecast up to 2022
Global Non-invasive Prenatal Testing Market: Snapshot Non-invasive prenatal testing (NIPT) has been garnering higher adoption especially in the cases of high risk pregnant women. Chromosomal disorders such as Edwards syndrome, down syndrome, Turner syndrome, and Patau syndrome are some of the diseases that can be screened using non-invasive prenatal testing. Gynecologists and pregnant women prefer the safety, non-invasiveness, and accuracy of non-invasive prenatal testing technology, although there are other testing techniques
2017 - 2021 : NIPT Test Market & Forecast
The Potential Non-Invasive Prenatal Testing(NIPT) Market is expected to reach more than USD 4 Billion across the 15 major markets(15MM) by the year end of 2021. Buy Now @: www.dpiresearch.com/report-details.php?P_ID=93 Long–term Growth Projection: More than 2.5 Million tests will be conducted by the 11 major NIPT test by the year end of 2021. Non-Invasive Prenatal Testing (NIPT) market size was valued at nearly USD 1 Billion in 2016 and market is expected to grow
2017-2023 : US NIPT Test Market
United States Non-Invasive Prenatal Testing(NIPT) Market is likely to reach nearly USD 1 Billion by the year end of 2023. Buy Now @ http://www.dpiresearch.com/report-details.php?P_ID=100 Market growth can be attributed to factors such as rapid penetration of high and average risk NIPT test, high incidence rate of babies born with down syndrome, no risk of miscarriage with NIPT, shifting trend towards child bearing at advanced maternal age (35 years or older), launch of